AllergoOncology: ultra‐low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)

Overview of attention for article published in Clinical and Translational Allergy, July 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#38 of 773)
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 6 public wall posts from 4 users.

📚 IgE immunodeficiency correlates with a significantly elevated risk of malignancy development. #EAACIPositionPaper #AllergoOncol…

EAACI position paper "AllergoOncology: Ultra-low IgE, a potential novel biomarker in cancer" from its AllergoOncology Task Force!

#IgE as a #biomarker in #cancer. An #EAACIpositionpaper analyzes the potential role of IgE in the tumor surveillance. #AllergoOnc…

AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity, including 2 additional Facebook posts.